VERACYTE, INC. Costs and Expenses
VERACYTE, INC. (VCYT) reported Costs and Expenses of $85.57 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-07-31
- VERACYTE, INC. costs and expenses for the quarter ending 2026-06-30 was $85.57M, a 9.96% decline year-over-year.
- VERACYTE, INC. costs and expenses for the quarter ending 2026-03-31 was $78.51M, a 2.49% increase year-over-year.
- VERACYTE, INC. costs and expenses for the quarter ending 2025-12-31 was $64.78M, a 13.14% decline year-over-year.
- VERACYTE, INC. costs and expenses for the quarter ending 2025-09-30 was $68.34M, a 2.00% increase year-over-year.
- VERACYTE, INC. costs and expenses for fiscal 2025 was $304.75M, a 8.07% increase from fiscal 2024.
- VERACYTE, INC. costs and expenses for fiscal 2024 was $282.00M, a 10.61% decline from fiscal 2023.
- VERACYTE, INC. costs and expenses for fiscal 2023 was $315.48M, a 45.54% increase from fiscal 2022.
- VERACYTE, INC. costs and expenses for fiscal 2022 was $216.76M, a 28.09% decline from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $85.57M 10-Q · filed 2026-07-31 | $164.08M 10-Q · filed 2026-07-31 | $228.86M derived: sum of 3 quarters · filed 2026-07-31 | $297.20M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | $78.51M 10-Q · filed 2026-05-06 | $143.29M derived: sum of 2 quarters · filed 2026-05-06 | $211.63M derived: sum of 3 quarters · filed 2026-05-06 | $306.66M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $64.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $133.11M derived: sum of 2 quarters · filed 2026-02-26 | $228.15M derived: sum of 3 quarters · filed 2026-07-31 | $304.75M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $68.34M 10-Q · filed 2025-11-05 | $163.37M derived: sum of 2 quarters · filed 2026-07-31 | $239.98M 10-Q · filed 2025-11-05 | $314.56M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | $95.04M 10-Q · filed 2026-07-31 | $171.64M 10-Q · filed 2026-07-31 | $246.22M derived: sum of 3 quarters · filed 2026-07-31 | $313.21M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $76.60M 10-Q · filed 2026-05-06 | $151.18M derived: sum of 2 quarters · filed 2026-05-06 | $218.18M derived: sum of 3 quarters · filed 2026-05-06 | $291.48M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $74.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $141.57M derived: sum of 2 quarters · filed 2026-02-26 | $214.88M derived: sum of 3 quarters · filed 2026-02-26 | $282.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $66.99M 10-Q · filed 2025-11-05 | $140.30M derived: sum of 2 quarters · filed 2025-11-05 | $207.42M 10-Q · filed 2025-11-05 | $307.72M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $73.31M 10-Q · filed 2025-08-07 | $140.43M 10-Q · filed 2025-08-07 | $240.73M derived: sum of 3 quarters · filed 2026-02-26 | $330.15M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $67.12M 10-Q · filed 2025-05-08 | $101.50M 10-Q · filed 2024-05-08 | $167.42M derived: sum of 2 quarters · filed 2026-02-26 | $256.85M derived: sum of 3 quarters · filed 2026-02-26 | $320.72M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $100.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $189.72M derived: sum of 2 quarters · filed 2026-02-26 | $253.59M derived: sum of 3 quarters · filed 2026-02-26 | $315.48M 10-K · filed 2026-02-26 | $446.85M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $89.43M 10-Q · filed 2024-11-07 | $121.85M 10-Q · filed 2023-11-08 | $153.30M derived: sum of 2 quarters · filed 2024-11-07 | $215.18M 10-Q · filed 2024-11-07 | $313.14M 10-Q · filed 2023-11-08 | $211.08M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $63.87M 10-Q · filed 2024-08-07 | $98.37M 10-Q · filed 2023-08-09 | $125.76M 10-Q · filed 2024-08-07 | $191.29M 10-Q · filed 2023-08-09 | $121.65M derived: sum of 3 quarters · filed 2025-02-28 | $206.93M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $92.92M 10-Q · filed 2024-05-08 | $57.78M derived: sum of 2 quarters · filed 2025-02-28 | $143.05M derived: sum of 3 quarters · filed 2025-02-28 | $226.65M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$35.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $50.13M derived: sum of 2 quarters · filed 2025-02-28 | $133.73M derived: sum of 3 quarters · filed 2025-02-28 | $216.76M 10-K · filed 2025-02-28 | $337.62M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $85.27M 10-Q · filed 2023-11-08 | $168.87M derived: sum of 2 quarters · filed 2023-11-08 | $251.90M 10-Q · filed 2023-11-08 | $331.57M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $83.60M 10-Q · filed 2023-08-09 | $166.63M 10-Q · filed 2023-08-09 | $246.30M derived: sum of 3 quarters · filed 2024-02-29 | $323.35M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $83.03M 10-Q · filed 2023-05-05 | $162.70M derived: sum of 2 quarters · filed 2024-02-29 | $239.75M derived: sum of 3 quarters · filed 2024-02-29 | $302.33M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $79.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $156.72M derived: sum of 2 quarters · filed 2024-02-29 | $219.30M derived: sum of 3 quarters · filed 2024-02-29 | $301.42M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $77.05M 10-Q · filed 2022-11-03 | $139.63M derived: sum of 2 quarters · filed 2022-11-03 | $221.75M 10-Q · filed 2022-11-03 | $264.36M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $62.58M 10-Q · filed 2022-08-03 | $144.70M 10-Q · filed 2022-08-03 | $187.31M derived: sum of 3 quarters · filed 2023-03-01 | $222.49M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $82.12M 10-Q · filed 2022-05-04 | $124.73M derived: sum of 2 quarters · filed 2023-03-01 | $159.91M derived: sum of 3 quarters · filed 2023-03-01 | $191.67M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $42.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $77.80M derived: sum of 2 quarters · filed 2023-03-01 | $109.55M derived: sum of 3 quarters · filed 2023-03-01 | $152.87M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $35.19M 10-Q · filed 2021-11-09 | $66.94M derived: sum of 2 quarters · filed 2021-11-09 | $110.26M 10-Q · filed 2021-11-09 | $148.19M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $31.75M 10-Q · filed 2021-07-29 | $75.08M 10-Q · filed 2021-07-29 | $113.00M derived: sum of 3 quarters · filed 2022-02-28 | $145.74M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $43.32M 10-Q · filed 2021-05-10 | $81.25M derived: sum of 2 quarters · filed 2022-02-28 | $113.98M derived: sum of 3 quarters · filed 2022-02-28 | $147.22M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $37.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $70.66M derived: sum of 2 quarters · filed 2022-02-28 | $103.90M derived: sum of 3 quarters · filed 2022-02-28 | $135.50M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $32.74M 10-Q · filed 2020-11-02 | $65.97M derived: sum of 2 quarters · filed 2020-11-02 | $97.57M 10-Q · filed 2020-11-02 | $126.38M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $33.24M 10-Q · filed 2020-07-30 | $64.83M 10-Q · filed 2020-07-30 | $93.64M derived: sum of 3 quarters · filed 2021-02-22 | $121.41M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $31.60M 10-Q · filed 2020-05-06 | $60.40M derived: sum of 2 quarters · filed 2021-02-22 | $88.17M derived: sum of 3 quarters · filed 2021-02-22 | $116.84M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | $28.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $56.58M derived: sum of 2 quarters · filed 2021-02-22 | $85.25M derived: sum of 3 quarters · filed 2021-02-22 | $114.24M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $27.77M 10-Q · filed 2019-10-22 | $56.44M derived: sum of 2 quarters · filed 2019-10-22 | $85.43M 10-Q · filed 2019-10-22 | $111.07M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $28.67M 10-Q · filed 2019-07-30 | $57.66M 10-Q · filed 2019-07-30 | $83.30M derived: sum of 3 quarters · filed 2020-02-25 | $107.19M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $29.00M 10-Q · filed 2019-04-30 | $54.64M derived: sum of 2 quarters · filed 2020-02-25 | $78.52M derived: sum of 3 quarters · filed 2020-02-25 | $103.54M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $25.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $49.53M derived: sum of 2 quarters · filed 2020-02-25 | $74.54M derived: sum of 3 quarters · filed 2020-02-25 | $98.49M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $23.89M 10-Q · filed 2018-10-29 | $48.90M derived: sum of 2 quarters · filed 2018-10-29 | $72.85M 10-Q · filed 2018-10-29 | |||||
| 2017-06-30 | $25.02M 10-Q · filed 2018-07-23 | $48.96M 10-Q · filed 2018-07-23 | ||||||
| 2017-03-31 | $23.95M 10-Q · filed 2018-05-01 | |||||||
| 2016-09-30 | $23.49M 10-Q · filed 2017-11-07 | $48.66M derived: sum of 2 quarters · filed 2017-11-07 | $71.96M 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | $25.17M 10-Q · filed 2017-07-31 | $48.47M 10-Q · filed 2017-07-31 | ||||||
| 2016-03-31 | $23.30M 10-Q · filed 2017-05-03 | |||||||
| 2015-09-30 | $21.22M 10-Q · filed 2016-11-03 | $42.20M derived: sum of 2 quarters · filed 2016-11-03 | $60.98M 10-Q · filed 2016-11-03 | |||||
| 2015-06-30 | $20.98M 10-Q · filed 2016-08-03 | $39.75M 10-Q · filed 2016-08-03 | ||||||
| 2015-03-31 | $18.77M 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |